Register Today for the 2023 Advocate Leadership Summit – May 6-8, 2023

News & Alerts

Call to Action Online – May 31, 2022

May 31, 2022

Advocate Leadership Summit Wrap-Up

Thank you to all who joined us for NBCC’s annual Advocate Leadership Summit! We were thrilled to host you in person for the first time since 2019. It was truly wonderful to see NBCC advocates face to face and once more enjoy the collaboration and networking that can only happen in that setting.   

This year’s program included an array of exciting plenary sessions featuring some of the most innovative voices in breast cancer research and advocacy.  

  • Drs. Fumiko Chino and Lee Newcomer joined Kent Rogers, Beth Emery, and Ivis Febus-Sampayo in a timely discussion about value-based cancer care 
  • NBCC President Fran Visco sat down with The Cancer Letter’s Paul Goldberg to share stories and insights from NBCC’s earliest days 
  • Drs. Naomi Ko, Melissa Davis, and Michelle Doose joined advocates Marylinn Minor and Ghecemy Lopez to engage in a crucial conversation about disparities in breast cancer and paths towards equity in health care 
  • Drs. Cyrus Ghajar, Keith Knutson, and Simon Knott, and advocates Pat Haugen and Michele Rakoff gave the annual update on their ongoing work with NBCC’s Artemis Project and how this work is fostering innovative breast cancer research, including the development of a preventative vaccine.  

There was also a timely and engaging political plenary featuring Jocelyn Frye of the National Partnership for Women & Families, Leslie Proll of the Conference on Civil and Human Rights, and advocate Judi Hirshfield-Bartek. They discussed strategies for advocates looking to accomplish their goals in the face of ongoing challenges to democracy—key among them ensuring equal voting rights. Monday’s political focus also featured two outstanding keynote speakers—Rep. Jamie Raskin and Neera Tanden. 

Attendees were also able to enjoy a variety of workshops aimed at honing their scientific understanding and advocacy skills. They heard from Capitol Hill staffers on crucial issues like how to build relationships with new members of Congress, as well as navigating advocacy in this new normal. They learned about the need for awareness about patient data online, as well as how to critically engage with cancer research in the news. The Summit also featured rigorous scientific workshops on topics including liquid biopsies, COVID-19 and cancer, new horizons in breast cancer metastasis research, and the ways in which evidence influences the launching of clinical trials. There were also tailored sessions for first-time advocates including an introduction to Congress, and an interactive round table discussion with seasoned NBCC advocates. Attendees were able to choose between different concurrent sessions in order to tailor their experience to suit their needs.  

As usual, the Summit was followed by our annual Lobby Day on May 3rd. Meetings were held through video conferencing and in-person. NBCC advocates participated in approximately 150 meetings and added 10 new cosponsors to the Metastatic Breast Cancer Access to Care Act. We look forward to adding additional new cosponsors soon. It is NBCC’s mission to ensure that, even through these challenging times, the needs of breast cancer patients and survivors will not be forgotten.  

Thank you again to everyone who joined us for the Summit. Your excitement and involvement made this event a success and we look forward to seeing you all again in person next spring! 

Donate Today 

The National Breast Cancer Coalition’s mission is to end breast cancer. Every dollar raised is immediately put to work advancing scientific research, collaborative workshops and symposia, advocacy training, and public policy work in Washington, DC, and in state capitals across the country in support of our mission.

Every minute counts in our efforts to achieve the goal of ending breast cancer. Every dollar equates to more lives saved.

Your gift is more than a contribution. It is an investment that will enable us to end breast cancer, once and for all.